newsfilter
← Latest News
ACCESS Newswire·

9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding Its GIP Antagonist NM-136 for Obesity

RALEIGH, NC / ACCESSWIRE / April 5, 2023 / 9 Meters Biopharma, Inc. , a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced receipt of